Skip to content

Person-checked company records fromPerson-checked records $750See a worked exampleHuman review in progress

Talk to sales

KeptIndex

IDEAYA Biosciences, Inc.

Select a Pol Theta development candidate

Delivered after the deadline

AI-confirmed · human review in progress Independent AI checks agreed on primary SEC or regulator evidence. Records are now being reviewed by hand, starting with those our customers order.

Announced
11 Jan 2021
Due
31 Dec 2021
Delivered
by 15 Aug 2022
  • Deadline
  • Met
  • Late
  • Not met
  • Today

What the company said

“Targeting PARG and Pol Theta Development Candidates in 2021”

What we found

Evidence strength A What the grades mean

The company did not select a Pol Theta development candidate in 2021 as originally targeted; they reported selecting the candidate in their August 2022 filing.

  • A
    IDEAYA Biosciences, Inc. 8-K filed 2022-05-10 Regulatory filing · published 10 May 2022 · retrieved 25 Oct 2026 · kept permanently by the SEC · fingerprint cecf248087d2
    “our potential first-in-class Pol Theta helicase inhibitor, for which we are collaborating with GSK to select a development candidate in Q2 2022.” ✓ confirmed on the page
  • A
    IDEAYA Biosciences, Inc. 10-Q filed 2022-08-15 Regulatory filing · published 15 Aug 2022 · retrieved 25 Oct 2026 · kept permanently by the SEC · fingerprint cda4be2d4c2f
    “In collaboration with GSK, we have selected a development candidate small molecule inhibitor of Pol Theta Helicase, or ATPase, domain.” ✓ confirmed on the page

Checked 25 Oct 2026.

Commitment DNA

The structured record of this commitment. Fields the company did not state are left blank rather than guessed.

Event type
Product other
Indicative materiality
Low rules
Action
Select
Deliverable
Pol Theta development candidate
Language
Aspirational (“aims”, “intends”)
In the company’s control
High
Specificity
High

How this entry was checked

  1. Commitment recordedThe company's words were matched word for word against the filing.
  2. First checkAn AI model, Gemini (Google), read the company's later filings and recorded the outcome with a quoted passage.
  3. Second check: agreesA different AI model, Claude (Anthropic), re-read the evidence without being told the outcome and reached the same answer.

Confirmed. This outcome counts towards the company's Kept Score. How verification works

Are you IDEAYA Biosciences, Inc.? You can publish an official statement next to this entry, free. Add a statement.

Is something here wrong or out of date? Companies and readers can ask us to check it. Please bring a link to a public source.

Report an error in this entry Reference: KI-C-2021-IDYA-021783 · Corrections policy

The Deadline Report

One email a week: the corporate commitments that came due, which were met, which slipped, and what is due next. Free. Stop any time.

No advertising. We never sell or share your address.